World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ANZCTR
Last refreshed on: 11 June 2018
Main ID:  ACTRN12618000864224
Date of registration: 22/05/2018
Prospective Registration: No
Primary sponsor: Ang Seng Bin
Public title: A pilot study of a customised nanotextile wet garment treatment on moderate and severe atopic dermatitis
Scientific title: A pilot study of a customised nanotextile wet garment treatment on moderate and severe atopic dermatitis
Date of first enrolment: 23/03/2017
Target sample size: 126
Recruitment status: Recruiting
URL:  http://www.anzctr.org.au/ACTRN12618000864224.aspx
Study type:  Interventional
Study design:  Randomised controlled trial  Parallel
Phase:  Not Applicable
Countries of recruitment
Contacts
Key inclusion & exclusion criteria
Health Condition(s) or Problem(s) studied
atopic dermatitis
Intervention(s)
Intervention: wet wrap therapy with wet wrap garment made of 100% nanopolyester. One garment set consists of a long sleeved shirt and a long pant, which covers the whole body except for head, neck, hands and feet. It comes with sizes for 6-24 month old, 2-5 year old, 5-8 year old, 8-11 year old, 11-14 year old, M size, L size, XL size and XXL size. A photo of patient wearing wet wrap therapy garment (Tubifast garment) can be found in attachment.

Participants will be recruited and issued with the wet wrap garment in dermatology clinic. Dermatology nurses will educate patients on the procedure of wet wrap therapy and instruct them to wear wet wrap garment overnight (4-8 hours) daily at home for 2 weeks.

Garment wearing procedure: 1. Soak wet wrap garment in lukewarm water, gently squeeze until not dripping. 2. After bathing patient, gently pat patient skin dry with towel. 3. Apply moisturizer and topical steroids as prescribed by doctor. 4. Dress patient in one layer of damp wet wrap garment. 5. Apply a dry layer of cloth on top of the wet wrap garment.

Patient will be reviewed on day 7 and day 14 of treatment in clinic and their adherence will be monitored and reminded during the visit.

Primary Outcome(s)
Secondary Outcome(s)
Secondary ID(s)
Source(s) of Monetary Support
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history